[Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a three-year prospective comparative study].
Ponomareva EV, Androsova LV, Krynskiy SA, Gavrilova SI · 2024 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova; 2024
Study findings
An open three-year study, described as randomly assigned, reported less cognitive decline and fewer conversions to dementia with repeated Cerebrolysin courses than no treatment.
- Population and setting
- 100 patients with amnestic mild cognitive impairment; 50 per group
- Evidence type
- Randomized trial
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Unblinded and no placebo; allocation details, attrition and event counts need full-text appraisal.
- The report does not by itself establish disease modification or dementia prevention.
- Full methods and risk of bias have not been independently assessed.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed record and available abstract checked; full text not reviewed.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Ponomareva EV, Androsova LV, Krynskiy SA, Gavrilova SI. [Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a three-year prospective comparative study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova; 2024 2024.
Molekul research summary: https://molekul.io/research/cbl-update-39435777. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry